QUESTCOR PHARMA INC
QCOR
QCOR was delisted on the 14th of August, 2014.
285 hedge funds and large institutions have $3.44B invested in QUESTCOR PHARMA INC in 2013 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 125 increasing their positions, 87 reducing their positions, and 43 closing their positions.
44% more repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 87
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
6% more capital invested
Capital invested by funds: $3.23B → $3.44B (+$207M)
5% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 43
0% more funds holding
Funds holding: 284 → 285 (+1)
57% less call options, than puts
Call options by funds: $177M | Put options by funds: $410M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
+$75.9M |
| 2 |
DM
Deerfield Management
New York
|
+$75.2M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$47.2M |
| 4 |
Bank of New York Mellon
New York
|
+$47.1M |
| 5 |
PC
Paulson & Co
New York
|
+$43.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$45.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$35.2M |
| 3 |
VCM
Valiant Capital Management
San Francisco,
California
|
-$31.4M |
| 4 |
BC
Broadwood Capital
New York
|
-$29.6M |
| 5 |
PA
Perceptive Advisors
New York
|
-$21.8M |
QCOR Hedge Fund Activity: Q4 2013 in Review
285 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in QUESTCOR PHARMA INC (QCOR) for Q4 2013, worth a combined $3.44B — up 6.4% from $3.23B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new QCOR positions and 43 closed out — a net gain of 2 holders — while 125 added to existing stakes and 87 trimmed.
The largest buyer was TIAA CREF Investment Management, adding an estimated $75.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $45.9M.
- 285 institutional investors held QUESTCOR PHARMA INC (QCOR) as of Q4 2013, up from 284 in Q3 2013.
- Funds reported $3.44B of QUESTCOR PHARMA INC stock for Q4 2013, up 6.4% quarter-over-quarter.
- 45 funds opened new QUESTCOR PHARMA INC positions in Q4 2013 and 43 closed out, a net change of +2 holders.
- The largest QUESTCOR PHARMA INC buyer in Q4 2013 was TIAA CREF Investment Management, an estimated $75.9M added.
- The largest QUESTCOR PHARMA INC seller in Q4 2013 was T. Rowe Price Associates, an estimated $45.9M sold.
Based on aggregated 13F filings for Q4 2013.